Suresh Katapalli Reddy, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 125 E Tower Park Dr, Waterloo, IA 50701 Phone: 319-234-5990 Fax: 319-234-5994 |
Dr. Srinivas Kalala, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1015 S Hackett Rd, Waterloo, IA 50701 Phone: 319-234-5990 |
Dr. Richard Alexander Manfready, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 1015 S Hackett Rd, Waterloo, IA 50701 Phone: 319-234-5990 Fax: 319-234-5994 |
Moaz Sial, Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1015 S Hackett Rd, Waterloo, IA 50701 Phone: 319-234-5990 |
Ravindra Mallavarapu, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1015 S Hackett Rd, Waterloo, IA 50701 Phone: 319-234-5990 |
News Archive
Columbia Engineering researchers report that Sofosbuvir-terminated RNA is more resistant to the proofreader of SARS-CoV-2, the virus that causes COVID-19, than Remdesivir-terminated RNA.
ChemoCentryx, Inc., today announced the initiation of a Phase II clinical trial for CCX168, an orally-administered small molecule for the treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a disease which can lead to renal and pulmonary failure.
Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced it has completed enrollment in its ongoing 200-patient Phase 2b study of AKB-6548 for the treatment of anemia associated with chronic kidney disease (CKD) in patients who are not dependent on dialysis.
A new study assesses antibody and functional T-cell responses at 6 months after complete vaccination with the Pfizer-BioNTech vaccine.
A Brief Report appearing in the American Journal of Preventive Medicine looks at testing rates for Hepatitis C virus (HCV) two years after the United States Preventive Services Task Force recommended it for all baby boomers, and finds rates are still very low.
› Verified 2 days ago